# Nobuyuki Katakami

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/nobuyuki-katakami/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,103 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 54 |
| i10-index | 139 |
| Last Known Institution | Takarazuka City Hospital |
| OpenAlex ID | https://openalex.org/A5102843956 |
| ORCID iD | https://orcid.org/0000-0002-1851-5788 |
| Works | 357 |

## Researcher papers

- [Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study](https://scholariq.org/papers/durvalumab-as-third-line-or-later-treatment-for-advanced-non-small-cell-lung/)
- [Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With <i>EGFR</i> T790M–Mutated Non–Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor](https://scholariq.org/papers/efficacy-of-osimertinib-plus-bevacizumab-vs-osimertinib-in-patients-with-i-egfr/)
- [Randomized Phase III Study Comparing Gefitinib With Erlotinib in Patients With Previously Treated Advanced Lung Adenocarcinoma: WJOG 5108L](https://scholariq.org/papers/randomized-phase-iii-study-comparing-gefitinib-with-erlotinib-in-patients-with/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [Takarazuka City Hospital](https://scholariq.org/institutions/takarazuka-city-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.